Applied DNA Sciences Inc (APDN)
0.3365
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
0.3331
0.00 (0.00%)
After-Hours: 20:00
Applied DNA Sciences Cash from Financing (TTM): -0.0351M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.0351M |
September 30, 2023 | 0.00 |
June 30, 2023 | 14.03M |
March 31, 2023 | 14.03M |
December 31, 2022 | 18.13M |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | 14.70M |
June 30, 2021 | 15.56M |
March 31, 2021 | 20.84M |
December 31, 2020 | 9.539M |
September 30, 2020 | 19.43M |
June 30, 2020 | 20.41M |
March 31, 2020 | 15.38M |
December 31, 2019 | 13.62M |
September 30, 2019 | 5.829M |
June 30, 2019 | 5.651M |
March 31, 2019 | 5.398M |
December 31, 2018 | 4.501M |
September 30, 2018 | 5.883M |
June 30, 2018 | 5.738M |
March 31, 2018 | 6.004M |
December 31, 2017 | 6.197M |
Date | Value |
---|---|
September 30, 2017 | 6.105M |
June 30, 2017 | 4.586M |
March 31, 2017 | 4.320M |
December 31, 2016 | 4.320M |
September 30, 2016 | 7.844M |
June 30, 2016 | 7.858M |
March 31, 2016 | 19.09M |
December 31, 2015 | 19.02M |
September 30, 2015 | 15.02M |
June 30, 2015 | 16.65M |
March 31, 2015 | 7.571M |
December 31, 2014 | 7.640M |
September 30, 2014 | 3.775M |
June 30, 2014 | 9.271M |
March 31, 2014 | 7.126M |
December 31, 2013 | 12.73M |
September 30, 2013 | 14.73M |
June 30, 2013 | 8.160M |
March 31, 2013 | 9.701M |
December 31, 2012 | 4.101M |
September 30, 2012 | 2.101M |
June 30, 2012 | 5.928M |
March 31, 2012 | 4.985M |
December 31, 2011 | 5.66M |
September 30, 2011 | 6.580M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.0351M
Minimum
Dec 2023
20.84M
Maximum
Mar 2021
12.48M
Average
14.03M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
Fonar Corp | -8.460M |
XWELL Inc | 0.008M |
ProPhase Labs Inc | 5.757M |
Veracyte Inc | 2.837M |
OncoCyte Corp | 12.19M |